Literature DB >> 7434082

A coagglutination method for presumptive identification of Salmonella typhi.

M Lesmana, R C Rockhill, W R Sanborn.   

Abstract

Salmonella group D, Vi and d antisera were used to sensitize A-containing staphylococcal cells. The coagglutination (COAG) reagents thus obtained, termed D-COAG, Vi-COAG and d-COAG were used to test growth taken from Kligler Iron Agar slants following 8-10 hours incubation. In 188 recently isolated strains of S. typhi, the D antigen was detected in 134 (71%) by direct reaction with the D-COAG reagent and 51 (27%) others following a simple treatment with 50% ethanol. Group D antigen was detected in the remaining 3 only following boiling of a suspension of each culture. The Vi-COAG reagent reacted with 184 (98%) of the cultures. The 4 remaining cultures were also negative for Vi antigen by the conventional slide agglutination test but D-COAG reagent was specific for other group D Salmonella but with none of the other groups tested, while the Vi-COAG reagent also reacted with a strain of Vi-containing Citrobacter furendii. The d-COAG reagent agglutinated with all S. typhi strains but none of the other non-S. typhi isolates tested.

Entities:  

Mesh:

Year:  1980        PMID: 7434082

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  3 in total

1.  Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi.

Authors:  Javier Santander; Soo-Young Wanda; Cheryl A Nickerson; Roy Curtiss
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

2.  Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.

Authors:  J Y Wang; F R Noriega; J E Galen; E Barry; M M Levine
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype Typhi.

Authors:  Javier Santander; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2008-12-01       Impact factor: 0.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.